Novo integrated sciences announces preliminary revenue range for fiscal 2022 third quarter

Bellevue, wash.--(business wire)---- $nvos #aapi--novo integrated sciences, inc. (nasdaq: nvos) (the “company” or “novo”), pioneering a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem of multiple patient and consumer touchpoints for services and product innovation, today announced that its preliminary unaudited revenue for the third quarter of fiscal 2022 is expected to be in the range of $13.4 million to $13.9 million, an increase of approximately 367% t
NVOS Ratings Summary
NVOS Quant Ranking